{
    "title": "Haleon believes it is not liable for any potential Zantac liabilities",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11230203/Haleon-believes-not-liable-potential-Zantac-liabilities.html",
    "date": "2022-09-20",
    "keywords": [
        "haleon",
        "gsk",
        "pfizer",
        "zantac",
        "consumer",
        "share",
        "litigation",
        "tuesday",
        "grover",
        "sanofi",
        "company",
        "health",
        "healthcare",
        "region",
        "indemnification",
        "pence",
        "reporting",
        "london",
        "drug",
        "companys",
        "ceo",
        "brian",
        "mcnamara",
        "compound",
        "carcinogen",
        "forerunner",
        "boehringer",
        "ingelheim",
        "plethora",
        "july",
        "business",
        "form",
        "interview",
        "result",
        "stance",
        "uncertainty",
        "outcome",
        "investor",
        "concern",
        "month",
        "market",
        "value",
        "worstcase",
        "scenario",
        "merck",
        "amp",
        "cos",
        "painkiller",
        "vioxx",
        "weedkiller",
        "note",
        "week",
        "credit",
        "suisse",
        "statement",
        "basis",
        "scope",
        "venture",
        "agreement",
        "jv",
        "position",
        "spokesperson",
        "respect",
        "comment",
        "gmt",
        "performance",
        "june",
        "profit",
        "period",
        "consensus",
        "forecast",
        "revenue",
        "growth",
        "raitano",
        "donovan",
        "jason"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}